Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 837-846

  Jiang, Shi Xu ^a   Kameya, Toru ^a,c   Sato, Yuichi ^a   Yanase, Nobuo ^a   Yoshimura, Hirokuni ^a   Kodama, Tetsuro ^b  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ADENOCARCINOMA; ARTICLE; CARCINOMA; CELL CULTURE; CELL DIFFERENTIATION; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; NEUROSECRETION; PATHOLOGY; SMALL CELL CARCINOMA; STAINING;

ADENOCARCINOMA; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CELL DIFFERENTIATION; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEUROSECRETORY SYSTEMS; PROTO-ONCOGENE PROTEINS C-BCL-2; STAINING AND LABELING; TUMOR CELLS, CULTURED;

EID: 0030091651     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80 879-886
2. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM Cloning of the chromosome breakpoint of neoplastic B cells with t(14, 18) chromosome translocation. Science 1984, 226.1097-1099
3. Tsujimoto Y, Croce CM Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986, 83:5214-5218
4. Hockenbery DM, Zutter M, Mickey W, Nahm M, Korsmeyer SJ. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88.6961-6965
5. Lu QL, Poulsom R, Wong L, Hanby AM: Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 1993, 169 431-437
6. Vaux D, Cory S, Adams J: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature 1988, 335:440-442
7. Lotem J, Sachs L Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ 1993, 4 41-47
8. Miyashita T, Reed JC: bcl-2. gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs Cancer Res 1992, 52:5407-5411
9. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991, 67:879-888
10. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993, 329:690-694
11. Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G. Small cell carcinomas of the lung express the bcl-2 protein. Am J Pathol 1994, 145:1036-1040
12. Tahara E. Molecular mechanism of stomach carcinogenesis J Cancer Res Clin Oncol 1993, 119.265-272
13. Lu QL, Elia G, Lucas S, Thomas JA- Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer 1993, 53 29-35
14. Castle VP, Heidelberger KP, Bromberg J, Ou XL, Dole M, Nunez G: Expression of the apoptosis-suppressing protein bci-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993, 143 1543-1550
15. McDonnell TJ, Korsmeyer SJ Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14,18). Nature 1991, 349: 254-256
16. Reed JC, Cuddy M, Slabiak T, Croce CM, Nowell PC. Oncogenic potential of bcl-2 demonstrated by gene transfer Nature 1988, 336 259-261
17. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation Cell 1989, 57:79-88
18. Merry DE, Veis DJ, Hickey WF, Korsmeyer SJ bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 1994, 120:301-311
19. Reed JC, Meister L, Tanaka S, Cuddy M, Yum S, Geyer C, Pleasure D: Differential expression of bc/2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res 1991, 51 6529-6538
20. Ramani P, Lu QL. Expression of bcl-2 gene product in neuroblastoma. J Pathol 1994, 172.273-278
21. Van den Oord JJ, Vandeghinste N, Ley MD, Wolf-Peeters CD: Bcl-2 expression in human melanocytes and melanocytic tumors. Am J Pathol 1994, 145:294-300
22. LeBrun DP, Warnke RA, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis Am J Pathol 1993, 142:743-753
23. Bensch KG, Cornn B, Pariente R, Spencer H: Oat cell carcinoma of the lung, its origin and relationship to bronchial carcinoid Cancer 1968, 22.1163-1172
24. Gazdar AF, Carney DN. Endocrine properties of small cell carcinoma of the lung. The Endocrine Lung in Health and Disease Edited by KL Becker, AF Gazdar. Philadelphia, WB Saunders, 1984, pp 501-509
25. Addis B, Hamid Q, Ibrahim NBN, Fahey M, Bloom SR, Polak JM: Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumors of the lung J Pathol 1987, 153:37-150
26. Kameya T, Shimosato Y, Kodama T, Tsumuraya M, Yamaguchi K, Abe K. Peptide hormone production by adenocarcinomas of the lung, its morphologic basis and histogenetic consideration. Virchows Arch (Pathol Anat) 1983, 400.245-254
27. Linnoila RI, Mulshine JL, Steinberg SM, Funa K, Matthews MJ, Cotelingam JD, Gazdar AF: Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 1988, 90 641-652
28. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y: Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 1994, 54.6-8
29. Jiang SX, Sato Y, Kuwao S, Kameya T Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol 1995, 177:35-138
30. WHO The World Health Organization histological typing of lung tumors Am J Clin Pathol 1982, 77 123-136
31. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, Chrousos G, Pass H, Doppman J: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15.529-553
32. Colby TV, Koss MN, Travis WD. Tumors of the lower respiratory tract. Atlas of tumor pathology Edited by TV Colby, MN Koss, WD Travis Washington DC, Armed Forces Institute of Pathology, 1995, pp 248-257
33. Pezzlla F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY Expression of the bcl-2 oncogene protein is not specific for the 14, 18 chromosomal translocation Am J Pathol 1990, 137:225-232
34. Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J- PGP 9.5: a new marker for vertebrate neurons and neuroendocrine cells. Brain Res 1983, 278 224-228
35. Kato K, Asano T, Kamiya N, Haimoto H, Hosoda S, Nagasaka A, Anyoshi Y, Ishiguro Y: Production of the α subunit of guanine nucleotide-binding protein Go by neuroendocrine tumors. Cancer Res 1987, 47-5800-5805
36. Miyake Y, Kodama T, Yamaguchi K: Pro-gastrin-releasing peptide (31-98) is a specific tumor marker in patients with small cell lung carcinoma. Cancer Res 1994, 54:2136-2140
37. Carbone DP, Minna JD: The molecular genetics of lung cancer. Adv Intern Med 1992, 37:153-171
38. Minna JD The molecular biology of lung cancer pathogenesis. Chest 1993, 103:449s-456s
39. Bissonnette RP, Exheverri F, Mahboubi A, Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992, 359:552-554
40. Fanidi A, Harrington EA, Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992, 359:554-556
41. Krajewski S, Chatten J, Hanada M, Reed JC. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas: comparisons with tumor cell differentiation and N-Myc protein. Lab Invest 1995, 72:42-54
42. Gazdar AF. Advances in the biology of non-small cell lung cancer. Chest 1986, 89:277s-283s